BMY vs CVBF · P/E 17, rev $24.46B vs P/E 14, rev $351.2M
Bristol-Myers Squibb Company (BMY) versus CVB Financial Corporation (CVBF) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
CVB Financial Corporation (CVBF) is a banks - regional company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported CVBF revenue for 2026-06-30 was $351.2M. Net income was $99.3M. CVBF currently screens at market cap $2.71B and trailing P/E 13.6.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. CVBF currently screens at market cap $2.71B and trailing P/E 13.6.
Not investment advice. Open the BMY and CVBF stock pages for the full models.
Not investment advice.